Home » Topics » Conferences

Conferences
RSS

Encouraging results reported for Merck anti-HIV combination

Jan. 30, 1997

Triple combination therapy dramatically effective in HIV/AIDS

Jan. 30, 1997

Doxil superior to other treatments for first-line treatment of Kaposi's sarcoma

Jan. 29, 1997

Combination HIV-IG/MAbs shows synergistic anti-HIV effects

Jan. 28, 1997

Preliminary results for potential new anti-HIV combination presented

Jan. 28, 1997

German investigators present potent dopamine D1 antagonist

Jan. 3, 1997

5-LO inhibitor under evaluation at SKB

Dec. 19, 1996

DuPont Merck developing atypical antipsychotic

Dec. 19, 1996

DuPont Merck reports ester prodrugs for glaucoma

Dec. 19, 1996

Innapharma reports novel antidepressant

Dec. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...